Kwality Pharmaceuticals Ltd.

Financial

	Kwality Pharma	Lincoln Pharma	Bharat Parenterals
Operational Metrics
Financials
5 yr Average ROE	25.87 %	15.94 %	12.73 %
5yr average Equity Multiplier	2.2	1.3	1.76
5yr Average Asset Turnover Ratio	1.09	0.84	0.86
5yr Avg Net Profit Margin	10.7 %	14.61 %	8.73 %
Price to Book	4.5	1.59	3.31
P/E	29.78	13.0	45.1
5yr Avg Cash Conversion Cycle	46.51 Days	24.49 Days	122.06 Days
Inventory Days	59.9 Days	42.89 Days	46.56 Days
Days Receivable	110.56 Days	90.22 Days	179.99 Days
Days Payable	112.27 Days	111.35 Days	95.97 Days
5yr Average Interest Coverage Ratio	15.91	58.2	22.68
5yr Avg ROCE	34.24 %	20.48 %	16.02 %
5yr Avg Operating Profit Margin	20.92 %	18.48 %	11.16 %
5 yr average Debt to Equity	0.52	0.0	0.26
5yr CAGR Net Profit	23.39 %	12.65 %	-9.67 %
5yr Average Return on Assets	12.43 %	12.28 %	8.0 %
Shareholdings
Promoter Holding	54.83 %	49.78 %	67.19 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.38 %	5.7 %	-6.65 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Kwality Pharma	Lincoln Pharma	Bharat Parenterals
Segment Break-Up	Segment Break-Up Formulations 100.0	-	-
Formulations Breakup	Formulations Breakup Others 100	-	-
Location Wise Break-Up	Location Wise Break-Up India 54.93 Rest of the World 0 Others 45.07	Location Wise Break-Up Rest of the World 55.8 India 44.2	Location Wise Break-Up Rest of the World 62.53 India 37.47